* NuVasive Inc NUVA.OQ NUVA.O is expected to show a rise in
quarterly revenue when it reports results on July 28.
* The San Diego, California-based company is expected to report
a 40.2% increase in revenue to $285.51 million from $203.61
million a year ago, according to the mean estimate from 17
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for NuVasive Inc is for
earnings of 44 cents per share. For the same quarter last year,
the company reported a loss of 40 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 8 "strong buy" or "buy," 8
"hold" and 3 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for NuVasive Inc is
$75, about 13.9% above its last closing price of $64.61.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 0.36 0.35 0.37 Beat 5.9
Dec. 31 2020 0.55 0.55 0.59 Beat 6.4
Sep. 30 2020 0.23 0.24 0.55 Beat 130.9
Jun. 30 2020 -0.40 -0.47 -0.40 Beat 15.6
Mar. 0.38 0.41 0.48 Beat 17.3
31 2020
Dec. 31 2019 0.64 0.64 0.73 Beat 14.3
Sep. 30 2019 0.54 0.53 0.59 Beat 10.5
Jun. 30 2019 0.56 0.56 0.63 Beat 13.1
This summary was machine generated July 26 at 21:20 GMT. All
figures in US dollars unless otherwise stated